Recombinant Human PMM2 Protein，His

PMM2 (phosphomannomutase 2) is an essential enzyme involved in the glycosylation pathway, particularly in the synthesis of GDP-mannose, a critical sugar nucleotide required for the proper functioning of various glycoproteins and glycolipids. Mutations in the PMM2 gene lead to congenital disorders of glycosylation (CDG), specifically CDG-Ib, characterized by a range of developmental and metabolic abnormalities. Understanding the structure and function of PMM2 is vital for elucidating the molecular mechanisms underlying these disorders. Recent research has focused on the recombinant expression of PMM2 in various systems to facilitate detailed biochemical and structural studies. By producing the enzyme in a controlled environment, scientists can investigate its catalytic properties, substrate specificity, and regulatory mechanisms. Such studies are essential for developing potential therapeutic strategies, including enzyme replacement therapy and small molecule drugs aimed at correcting the enzymatic deficiencies associated with PMM2 mutations. Furthermore, advances in protein engineering techniques allow for the modification of PMM2 to enhance its stability and activity, paving the way for innovative treatment approaches for patients suffering from PMM2-related diseases. Overall, the study of recombinant PMM2 not only enhances our understanding of glycosylation pathways but also holds promise for the development of targeted therapies for CDG-Ib and related conditions.